Rare Disease Report

Current Clinical Trials for Neuromyelitis Optica

APRIL 22, 2015

Neuromyelitis optica is a rare autoimmune condition that currently has no orphan drug approved for treatment.

n this video, Michael Levy, MD, of Johns Hopkins Medicine in Baltimore, Maryland, discusses the numerous clinical trials in which his clinic is involved to learn more about managing this condition. 

For more information, click here

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.